Archvest Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
1,024
+116
+13% +$27K 0.15% 66
2026
Q1
$222K Sell
908
-415
-31% -$96.7K 0.14% 68
2025
Q4
$274K Buy
1,323
+3
+0.2% +$593 0.17% 52
2025
Q3
$245K Buy
+1,320
New +$226K 0.22% 54
2025
Q2
Sell
-1,303
Closed -$216K 65
2025
Q1
$216K Sell
1,303
-152
-10% -$23.8K 0.18% 61
2024
Q4
$210K Buy
+1,455
New +$225K 0.15% 59
2024
Q2
Sell
-1,650
Closed -$260K 64
2024
Q1
$260K Buy
+1,650
New +$263K 0.18% 53

Other funds holding JNJ

Archvest Wealth Advisors's JNJ Position: Q2 2026 in Review

Archvest Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, buying an estimated $27K and bringing the position to 1,024 shares worth $260K. The position accounts for 0.15% of the portfolio, ranked #66.

Archvest Wealth Advisors first reported a position in JNJ in Q1 2024 and has held it in 7 quarters since. The position peaked at $274K in Q4 2025. 4,678 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Archvest Wealth Advisors held 1,024 shares of Johnson & Johnson worth $260K as of Q2 2026.
  • Archvest Wealth Advisors bought 116 Johnson & Johnson shares in Q2 2026, an estimated $27K.
  • Johnson & Johnson made up 0.15% of Archvest Wealth Advisors's portfolio in Q2 2026, its #66 holding.
  • Archvest Wealth Advisors first reported a position in Johnson & Johnson in Q1 2024 and has held it in 7 quarters since.
  • Archvest Wealth Advisors's Johnson & Johnson position peaked at $274K in Q4 2025.
  • 4,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Archvest Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.